These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Propofol-Based Palliative Sedation to Treat Antipsychotic-Resistant Agitated Delirium. Covarrubias-Gómez A, López Collada-Estrada M. J Pain Palliat Care Pharmacother; 2017; 31(3-4):190-194. PubMed ID: 28506099 [Abstract] [Full Text] [Related]
3. The use of propofol in palliative medicine. Moyle J. J Pain Symptom Manage; 1995 Nov; 10(8):643-6. PubMed ID: 8594126 [Abstract] [Full Text] [Related]
4. 'Palliative sedation'? A retrospective cohort study on the use and labelling of continuously administered sedatives on a palliative care unit. Schildmann E, Pörnbacher S, Kalies H, Bausewein C. Palliat Med; 2018 Jul; 32(7):1189-1197. PubMed ID: 29557260 [Abstract] [Full Text] [Related]
5. High-dose propofol drip for palliative sedation: a case report. Herndon CM, Zimmerman E. Am J Hosp Palliat Care; 2018 Jul; 25(6):492-5. PubMed ID: 18550779 [Abstract] [Full Text] [Related]
6. Palliative sedation: A safety net for the relief of refractory and intolerable symptoms at the end of life. Patel C, Kleinig P, Bakker M, Tait P. Aust J Gen Pract; 2019 Dec; 48(12):838-845. PubMed ID: 31774984 [Abstract] [Full Text] [Related]
7. Propofol in terminal care. Mercadante S, De Conno F, Ripamonti C. J Pain Symptom Manage; 1995 Nov; 10(8):639-42. PubMed ID: 8594125 [Abstract] [Full Text] [Related]
8. Palliative sedation: when the family and consulting service see no alternative. Del Fabbro E, Reddy SG, Walker P, Bruera E. J Palliat Med; 2007 Apr; 10(2):488-92. PubMed ID: 17472523 [No Abstract] [Full Text] [Related]
9. Dexmedetomidine Versus Midazolam for End-of-Life Sedation and Agitation: Protocol for a Randomized Controlled Trial (The DREAMS Trial). Thomas B, Barclay G, Lo WA, Mullan J, Mansfield K. JMIR Res Protoc; 2024 Sep 04; 13():e55129. PubMed ID: 39230940 [Abstract] [Full Text] [Related]
10. Current practice and perceptions regarding pain, agitation and delirium management in patients receiving venovenous extracorporeal membrane oxygenation. Dzierba AL, Abrams D, Madahar P, Muir J, Agerstrand C, Brodie D. J Crit Care; 2019 Oct 04; 53():98-106. PubMed ID: 31202165 [Abstract] [Full Text] [Related]
12. Successful Use of Propofol After Failed Palliative Sedation in Patients With Refractory Symptoms. Garcia Romo E, Pfang B, Valle Borrego B, Lobo Antuña M, Noguera Tejedor A, Rubio Gomez S, Galindo Vazquez V, Prieto Rios B. J Palliat Med; 2024 Oct 04; 27(10):1339-1345. PubMed ID: 38973718 [Abstract] [Full Text] [Related]
13. Discussions about palliative sedation in hospice: Frequency, timing and factors associated with patient involvement. Ingravallo F, de Nooijer K, Pucci V, Casini C, Miccinesi G, Rietjens JAC, Morino P. Eur J Cancer Care (Engl); 2019 May 04; 28(3):e13019. PubMed ID: 30773765 [Abstract] [Full Text] [Related]
14. A Review of Palliative Sedation. Bobb B. Nurs Clin North Am; 2016 Sep 04; 51(3):449-57. PubMed ID: 27497018 [Abstract] [Full Text] [Related]
15. Refractory hyperactive delirium in the dying: pharmacological management. Tham K, Shiu A, William L, Walpole G, Rashed S. BMJ Support Palliat Care; 2022 Dec 04; 12(4):471-474. PubMed ID: 34819327 [Abstract] [Full Text] [Related]
17. Propofol-based palliative sedation in terminally ill children with solid tumors: A case series. Miele E, Angela M, Cefalo MG, Del Bufalo F, De Pasquale MD, Annalisa S, Spinelli GP, Luigi S. Medicine (Baltimore); 2019 May 04; 98(21):e15615. PubMed ID: 31124940 [Abstract] [Full Text] [Related]